Key Insights

Highlights

Success Rate

86% trial completion

Published Results

229 trials with published results (22%)

Research Maturity

687 completed trials (65% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

10.3%

110 terminated out of 1065 trials

Success Rate

86.2%

-0.3% vs benchmark

Late-Stage Pipeline

33%

353 trials in Phase 3/4

Results Transparency

33%

229 of 687 completed with results

Key Signals

229 with results86% success110 terminated

Data Visualizations

Phase Distribution

848Total
Not Applicable (245)
Early P 1 (5)
P 1 (57)
P 2 (188)
P 3 (223)
P 4 (130)

Trial Status

Completed687
Unknown112
Terminated110
Recruiting60
Withdrawn37
Not Yet Recruiting31

Trial Success Rate

86.2%

Benchmark: 86.5%

Based on 687 completed trials

Clinical Trials (1065)

Showing 20 of 20 trials
NCT07738510Phase 2Not Yet Recruiting

Evaluate Ofirnoflast in Adults With Very Low- to Intermediate-risk Myelodysplastic Syndromes Requiring Transfusions

NCT02048813Phase 3Active Not RecruitingPrimary

Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

NCT01572506Phase 1CompletedPrimary

Mechanisms Accounting for Unexplained Anemia in the Elderly

NCT07725497Phase 2RecruitingPrimary

A Study of Luspatercept in People With Anemia

NCT07623161Phase 3Recruiting

A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib

NCT07422480Phase 3Recruiting

A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

NCT05750654Not ApplicableCompletedPrimary

SHIIFT: Small Tubes to Halt Medical ICU/IMU Frequent Transfusions

NCT03369210Phase 3Completed

Liberal Transfusion Strategy in Elderly Patients

NCT07715318Phase 2Not Yet RecruitingPrimary

Efficacy and Safety of Spironolactone in Pediatric Hemodialysis Patients With Anemia.

NCT05320198Phase 1Recruiting

Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

NCT07708025Phase 3Completed

Oral Iron for the Management of Iron Deficiency Anemia in SGLT2i-Treated Heart Failure Patients

NCT04717414Phase 3Active Not Recruiting

An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Subjects With Myeloproliferative Neoplasm-Associated Myelofibrosis on Concomitant JAK2 Inhibitor Therapy and Who Require Red Blood Cell Transfusions

NCT07701499Not Yet RecruitingPrimary

Validation of Non-Invasive Hemoglobin Measurement Using Optical Method for Anemia Screening Among Adults in Jakarta

NCT07368972Phase 2Recruiting

Study of DISC-0974-201 in Participants With IBD and Anemia

NCT07699666Not ApplicableRecruiting

Delayed Versus Immediate Cord Clamping in Preterm Birth

NCT05699005Phase 1Recruiting

Individualized or Conventional Transfusion Strategies During Peripheral VA-ECMO

NCT07678762Not ApplicableActive Not Recruiting

Multicenter, Prospective Study Evaluating the Accuracy of an AI-based Smartphone Application for Non-invasive Anemia Detection

NCT07671469Not ApplicableNot Yet Recruiting

Personalized Blood Transfusion Protocol for Cardiac Patients

NCT06042699Not ApplicableRecruiting

Kids With Iron Deficiency and Scoliosis

NCT07661602Phase 3Not Yet RecruitingPrimary

How Precision Diets, Through Gut Bacteria, Affect Anemia in Nepalese Adolescent

Scroll to load more

Research Network

Activity Timeline